Synapse

← Bruce D. Walker

Papers by Bruce D. Walker

Page 9 · newest first

  1. Cytotoxic T-Lymphocyte (CTL) Responses Directed against Regulatory and Accessory Proteins in HIV-1 InfectionDNA and Cell Biology · 2002
  2. Absence of biologically important Kaposi sarcoma–associated herpesvirus gene products and virus-specific cellular immune responses in multiple myelomaBlood · 2002
  3. Comprehensive Analysis of CD8⁺-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted SpecificitiesJournal of Virology · 2002
  4. Cellular immune responses against hepatitis C virus: the evidence base 2002Clinical & Experimental Immunology · 2002
  5. Ventricular tachycardia following ingestion of a commonly used antihistamineThe Medical Journal of Australia · 2002
  6. HIV-1 Vpu represents a minor target for cytotoxic T lymphocytes in HIV-1-infectionAIDS · 2002
  7. Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infectionJournal of Clinical Investigation · 2002
  8. Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent VirusesJournal of Virology · 2002
  9. Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infectionJournal of Clinical Investigation · 2002
  10. Nef-Mediated Resistance of Human Immunodeficiency Virus Type 1 to Antiviral Cytotoxic T LymphocytesJournal of Virology · 2002
  11. Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responsesAIDS · 2002
  12. Immunologic Control of HIV-1Annual Review of Medicine · 2002
  13. Neutralizing Antibodies Associated with Viremia Control in a Subset of Individuals after Treatment of Acute Human Immunodeficiency Virus Type 1 InfectionJournal of Virology · 2001
  14. Multiple Effector Functions Mediated by Human Immunodeficiency Virus-Specific CD4⁺T-Cell ClonesJournal of Virology · 2001
  15. Vpr Is Preferentially Targeted by CTL During HIV-1 InfectionThe Journal of Immunology · 2001
  16. Noncytolytic Inhibition of X4 Virus by Bulk CD8⁺Cells from Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Persons and HIV-1-Specific Cytotoxic T Lymphocytes Is Not Mediated by β-ChemokinesJournal of Virology · 2001
  17. Investigation of Primary Human Immunodeficiency Virus Infection in Patients Who Test Positive for Heterophile AntibodyClinical Infectious Diseases · 2001
  18. Relative Dominance of Epitope-Specific Cytotoxic T-Lymphocyte Responses in Human Immunodeficiency Virus Type 1-Infected Persons with Shared HLA AllelesJournal of Virology · 2001
  19. Definition of an Optimal Cytotoxic T Lymphocyte Epitope in the Latently Expressed Kaposi's Sarcoma–Associated Herpesvirus Kaposin ProteinThe Journal of Infectious Diseases · 2001
  20. Hepatitis C Virus InfectionNew England Journal of Medicine · 2001
  21. Sustained Dysfunction of Antiviral CD8⁺T Lymphocytes after Infection with Hepatitis C VirusJournal of Virology · 2001
  22. Human Immunodeficieny Virus Pathogenesis and Prospects for Immune Control in Patients with Established InfectionClinical Infectious Diseases · 2001
  23. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosityProceedings of the National Academy of Sciences · 2001
  24. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individualsProceedings of the National Academy of Sciences · 2001
  25. Rapid Definition of Five Novel HLA-A∗3002-Restricted Human Immunodeficiency Virus-Specific Cytotoxic T-Lymphocyte Epitopes by Elispot and Intracellular Cytokine Staining AssaysJournal of Virology · 2001
  26. Identification of Novel HLA-A2-Restricted Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Epitopes Predicted by the HLA-A2 Supertype Peptide-Binding MotifJournal of Virology · 2001
  27. HIV versus the immune system: another apparent victory for the virusJournal of Clinical Investigation · 2001
  28. Detection of Diverse Hepatitis C Virus (HCV)-Specific Cytotoxic T Lymphocytes in Peripheral Blood of Infected Persons by Screening for Responses to All Translated Proteins of HCVJournal of Virology · 2001
  29. Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 InfectionThe Journal of Experimental Medicine · 2001
  30. Substantial Differences in Specificity of HIV-Specific Cytotoxic T Cells in Acute and Chronic HIV InfectionThe Journal of Experimental Medicine · 2001
  31. Functionally Inert HIV-Specific Cytotoxic T Lymphocytes Do Not Play a Major Role in Chronically Infected Adults and ChildrenThe Journal of Experimental Medicine · 2000
  32. The Role of CD4+ T Cell Help and CD40 Ligand in the In Vitro Expansion of HIV-1-Specific Memory Cytotoxic CD8+ T Cell ResponsesThe Journal of Immunology · 2000
  33. Cellular Immunity to Human Immunodeficiency Virus Type 1 (HIV‐1) Clades: Relevance to HIV‐1 Vaccine Trials in UgandaThe Journal of Infectious Diseases · 2000
  34. Marked Differences in Quantity of Infectious Human Immunodeficiency Virus Type 1 Detected in Persons with Controlled Plasma Viremia by a Simple Enhanced Culture MethodJournal of Clinical Microbiology · 2000
  35. Comparative effects of azimilide and ambasilide on the human ether-a-go-go-related gene (HERG) potassium channelCardiovascular Research · 2000
  36. Antiretroviral resistance during successful therapy of HIV type 1 infectionProceedings of the National Academy of Sciences · 2000
  37. Identification of Dominant Optimal HLA-B60- and HLA-B61-Restricted Cytotoxic T-Lymphocyte (CTL) Epitopes: Rapid Characterization of CTL Responses by Enzyme-Linked Immunospot AssayJournal of Virology · 2000
  38. Characterization of a Novel Respiratory Syncytial Virus-Specific Human Cytotoxic T-Lymphocyte EpitopeJournal of Virology · 2000
  39. Inhibition of HERG potassium channels by the antimalarial agent halofantrineBritish Journal of Pharmacology · 2000
  40. Impaired CTL Recognition of Cells Latently Infected with Kaposi’s Sarcoma-Associated Herpes VirusThe Journal of Immunology · 2000
  41. Inhibition of Human Immunodeficiency Virus Type 1 Replication in Primary CD4⁺T Lymphocytes, Monocytes, and Dendritic Cells by Cytotoxic T LymphocytesJournal of Virology · 2000
  42. Differential Narrow Focusing of Immunodominant Human Immunodeficiency Virus Gag-Specific Cytotoxic T-Lymphocyte Responses in Infected African and Caucasoid Adults and ChildrenJournal of Virology · 2000
  43. HLA-B57-Restricted Cytotoxic T-Lymphocyte Activity in a Single Infected Subject toward Two Optimal Epitopes, One of Which Is Entirely Contained within the OtherJournal of Virology · 2000
  44. Analysis of Successful Immune Responses in Persons Infected with Hepatitis C VirusThe Journal of Experimental Medicine · 2000
  45. Unusual Polymorphisms in Human Immunodeficiency Virus Type 1 Associated with Nonprogressive InfectionJournal of Virology · 2000
  46. Efficient Processing of the Immunodominant, HLA-A*0201-Restricted Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitope despite Multiple Variations in the Epitope Flanking SequencesJournal of Virology · 1999
  47. Treatment of Human Immunodeficiency Virus Infection with Hydroxyurea, Didanosine, and a Protease Inhibitor before Seroconversion Is Associated with Normalized Immune Parameters and Limited Viral ReservoirThe Journal of Infectious Diseases · 1999
  48. Recurrent Atrial Electrode Displacement Complicating a Single Lead VDD Pacing SystemPacing and Clinical Electrophysiology · 1999
  49. Hydroxyurea and Didanosine Long-Term Treatment Prevents HIV Breakthrough and Normalizes Immune ParametersAIDS Research and Human Retroviruses · 1999
  50. Inhibition of the human ether‐a‐go‐go‐related gene (HERG) potassium channel by cisapride: affinity for open and inactivated statesBritish Journal of Pharmacology · 1999